Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.

Abstract excerpt

As a target for gene therapy, Duchenne muscular dystrophy (DMD) presents many obstacles but also an unparalleled prospect for correction by alternative splicing. The majority of mutations in the dystrophin gene occur in the region encoding the spectrin-like central rod domain, which is largely dispensable. Thus, splicing around mutations can generate a shortened but in-frame transcript, permitting translation of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Dystrophin
• Share to Genetic Therapy